Managing Anticoagulated Patients with Obesity: Focus on Direct Oral Anticoagulants Enduring

This course has expired for CME credit, however you can still view and access the event recording.

ACTIVITY DESCRIPTION / STATEMENT OF NEED:

This activity will address the complexity of managing patients with obesity who require anticoagulation, with a particular focus on the use of direct oral anticoagulants (DOACs). As obesity has become increasingly common, how to best treat these patients with anticoagulation is a frequently encountered clinical question. In this program, speakers from several subspecialties (endocrinology, cardiology, hematology, and bariatric surgery) will review the current medical literature on DOAC use in patients with obesity and provide their unique perspectives to address this question. The activity will conclude with a case-based debate and Q&A session to facilitate interdisciplinary discussion and provide insights on best management strategies.

The content of this internet enduring material activity was originally presented as part of a live event. Learners must view all videos in their entirety and complete a post-activity assessment and evaluation before they are eligible for continuing credit. 

TARGET AUDIENCE

This activity has been designed for physicians, nurse practitioners, physician assistants, pharmacists, and other clinicians specializing in cardiology, emergency medicine, endocrinology, family medicine, hematology/oncology, hospital medicine, internal medicine, surgery, and vascular medicine.

LEARNING OBJECTIVES:

By the end of the session the participant will be able to:

• Describe best practices for defining and measuring obesity, and the complexity revolving around the management of obesity
• Recognize the unique clinical challenges that may impact DOAC use in patients with obesity
• Discuss the latest data on indications for DOAC use in patients with obesity, including atrial fibrillation, VTE, and in the setting of bariatric surgery
• Identify limitations of various guideline recommendations pertaining to DOAC use in patients with obesity
• Assess optimal prophylactic and therapeutic anticoagulation strategies in patients with obesity

AGENDA

VIDEO AGENDA

An Internist’s Perspective: Understanding Obesity and its Management Judy Shiau, MD, Dipl.of ABOM – Associate Professor, Division of Endocrinology and Metabolism and Program Director for the Bariatric Medicine Fellowship at the University of Ottawa; General Internist and Medical Director of LEAF Weight Management Clinic® A Cardiologist’s Perspective: How I Treat my Patients with Obesity and CVD (including AFib) Aaron Aday, MD, MSc – Investigator, Vanderbilt Translational and Clinical Cardiovascular Research Center at Vanderbilt University Medical Center A Hematologist’s Perspective: How I Treat my Patients with Obesity and VTE Tzu-Fei Wang, MD, MPH – Associate Professor of Medicine at The University of Ottawa in the Division of Hematology A Bariatric Surgeon’s Perspective: How I Treat my Anticoagulated Patients Undergoing Bariatric Surgery Malcolm K. Robinson, MD – Associate Professor at Harvard Medical School; Vice Chairman of the Department of Surgery for Clinical Operations, Surgical Director of Perioperative Services, and Director of the Nutrition Support Service at Brigham and Women’s Hospital Case-Based Debates and Q&A: Moderated by Allen Taylor, MD – Chairman of Cardiology at MedStar Heart and Vascular Institute Case 1: DOAC Use in a Patient with Obesity and AFib Aaron Aday, MD, MSc – Investigator, Vanderbilt Translational and Clinical Cardiovascular Research Center at Vanderbilt University Medical Center Case 2: DOAC Use in a Patient with Obesity and VTE Tzu-Fei Wang, MD, MPH – Associate Professor of Medicine at The University of Ottawa in the Division of Hematology Case 3: DOAC Use in a Patient Who Has Undergone Bariatric Surgery Malcolm K. Robinson, MD – Associate Professor at Harvard Medical School; Vice Chairman of the Department of Surgery for Clinical Operations, Surgical Director of Perioperative Services, and Director of the Nutrition Support Service at Brigham and Women’s Hospital Panel Discussion

FACULTY DISCLOSURES AND RESOLUTION OF COI

Aaron Aday, MD, MSc: Paid Consultant – OptumCare

Allen Taylor, MD: Speaker – Amgen, Esperion

Judy Shiau, MD, Dipl.of ABOM: Speaker – Bausch Health, Novonordisk, Abbvie; Advisor – Bausch Health, Novonordisk; Research Grant – Bausch Health, Nestle Health Science

Tzu-Fei Wang, MD, MPH: Research Grant – Leo Pharma; Advisory Board – Servier

Individuals with no conflicts of interest to disclose: 

• Content reviewer: Charles J Turck, PharmD, BCPS, BCCCP, President, ScientiaCME
• Malcolm K. Robinson, MD